On April 13, 2021, Timber Pharmaceuticals, Inc. received notice from Michael Derby, Executive Chairman of the company's Board of Directors (the Board"), that he will step down and resign as an officer and director of the company effective April 16, 2021. Mr. Derby's resignation is not the result of any disagreement with the Company on any matter relating to its operations, policies or practices. There are no disagreements between the Company and Mr. Derby regarding Mr. Derby's resignation. Mr. Derby indicated that he felt he had achieved his goal of forming the company and overseeing its initial year of operations after becoming a public company.